KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Shares Outstanding (Diluted Average): 2009-2025

Historic Shares Outstanding (Diluted Average) for Teva Pharmaceutical Industries (TEVA) over the last 13 years, with Sep 2025 value amounting to $1.2 billion.

  • Teva Pharmaceutical Industries' Shares Outstanding (Diluted Average) rose 2.74% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 2.74%. This contributed to the annual value of $1.1 billion for FY2024, which is 1.07% up from last year.
  • According to the latest figures from Q3 2025, Teva Pharmaceutical Industries' Shares Outstanding (Diluted Average) is $1.2 billion, which was up 0.26% from $1.2 billion recorded in Q2 2025.
  • In the past 5 years, Teva Pharmaceutical Industries' Shares Outstanding (Diluted Average) ranged from a high of $1.2 billion in Q3 2025 and a low of $1.1 billion during Q1 2021.
  • Over the past 3 years, Teva Pharmaceutical Industries' median Shares Outstanding (Diluted Average) value was $1.1 billion (recorded in 2024), while the average stood at $1.1 billion.
  • In the last 5 years, Teva Pharmaceutical Industries' Shares Outstanding (Diluted Average) decreased by 0.18% in 2024 and then increased by 3.21% in 2025.
  • Quarterly analysis of 5 years shows Teva Pharmaceutical Industries' Shares Outstanding (Diluted Average) stood at $1.1 billion in 2021, then grew by 0.27% to $1.1 billion in 2022, then grew by 0.81% to $1.1 billion in 2023, then grew by 1.07% to $1.1 billion in 2024, then climbed by 2.74% to $1.2 billion in 2025.
  • Its Shares Outstanding (Diluted Average) was $1.2 billion in Q3 2025, compared to $1.2 billion in Q2 2025 and $1.2 billion in Q1 2025.